麻豆果冻传媒影音

Numerical advantage in randomized trial, non-randomized study misses noninferiority mark

In three trials, about 40% of patients with brain metastases recovered neurocognitive function

"It really shows us that we have two great options," expert says

Detectable circulating tumor DNA before radiotherapy linked with worse survival

Time to treatment completion slashed by over 4 hours compared with CT simulation planning

Randomized trial a "game changer" for patients who have implant-based reconstruction, expert says

Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks

Intercourse and/or vaginal dilation reduces risk of vaginal stenosis

Phase II study shows 100% local control and cancer-specific survival after more than 3 years

Radiotherapy led to "dramatic" slowing of progression, increased time with normal testosterone

SMART safe in patients with borderline or locally advanced cancer, with encouraging early OS data

Reduces treatment time, noninferior to conventional RT with sequential boost after lumpectomy

Fewer skeletal events, less pain unexpectedly followed by longer life

Much less likely than men to be queried about sexual function when receiving treatment